Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

BioTalk with Rich Bendis

Unveiling the Life Sciences Landscape: Insights from CBRE Experts on BioTalk with Rich Bendis

25 Jun 2023

Description

Are you curious to discover how experts navigate the complex landscape of life sciences real estate? Want to stay ahead of the curve in the market today? Ready to learn about the latest talent dynamics in the field? Join Rich Bendis on BioTalk as he discusses the world of life sciences real estate and market trends with CBRE's experts, Dan Grimes, Senior VP at CBRE's Mid-Atlantic Life Sciences practice, and Ian Anderson, Senior Director of Research and Analysis. Together, they discuss the 2023 "US Life Sciences Research Talent Report" and the BioHealth Capital Region's Top 3 ranking. Discover how Dan's expertise in real estate strategies for BioHealth companies and investors shapes success in the industry. Gain valuable insights from Ian's extensive experience in commercial real estate and capital markets as he guides decision-making in the life sciences, office, and healthcare sectors. They discuss major BioHealth projects, delve into talent dynamics, and analyze market trends. This conversation offers valuable perspectives, from the evolution of the "US Life Sciences Research Talent Report" to the changing landscape of the top 25 US metros and emerging hubs. Gain a comprehensive understanding of the intricate world of life sciences, from real estate strategies to talent dynamics and market trends. Don't miss this opportunity to gain exclusive insights from CBRE's experts and decode the complexities of life sciences on BioTalk with Rich Bendis.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.